The 'lost' HIV population: Time to refocus our clinical and research efforts

AIDS

Volumn 23, Issue 1, 2009, Pages 145-146

  Harding, Richard ^a   Krakauer, Eric L ^b   Sithole, Zodwa ^c   De Lima, Liliana ^d,e   Selman, Lucy ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Hospice Palliative Care Association of South Africa   (South Africa)

^d Latin American Association for Palliative Care   (Argentina)

^e International Association for Hospice and Palliative Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROVASCULAR DISEASE; COMORBIDITY; DELAYED DIAGNOSIS; DETERIORATION; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH PROMOTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LETTER; LIVER FAILURE; MORBIDITY; MORTALITY; PALLIATIVE THERAPY; PATIENT CARE; PATIENT COMPLIANCE; POPULATION RESEARCH; POVERTY; PRIORITY JOURNAL; QUALITY OF LIFE; THERAPY DELAY; TREATMENT FAILURE; TREATMENT REFUSAL;

BIOMEDICAL RESEARCH; CONGRESSES AS TOPIC; HIV INFECTIONS; HUMANS; TERMINAL CARE; WORLD HEALTH;

EID: 58149107231     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32831de90b     Document Type: Letter

References (7)

1. Tuboi S, Shepherd B, Cesar C, Krolewiecki A, Cahn P, Wolff M, et al. Mortality during the first year of potent antiretroviral therapy in HIV-1-infected patients from 5 treatment centers in the Caribbean and Latin America. XVII International AIDS Conference; 13-18 August 2008; Mexico City. Mexico City: International AIDS Society; 2008.
2. Puvimanasinghe JPA, Ndwapi N, Gaolathe T, Musuka G, Manthe L, Moeti T, et al. Six years of HAART in the public sector of Botswana. XVII International AIDS Conference; 13-18 August 2008; Mexico City. Mexico City: International AIDS Society; 2008.
3. Sierra Madero J, Villasis A, Mendez P, Mosqueda JL, Torres I, Gutierrez F, et al. A prospective, randomized, open label trial of efavirenz versus lopinavir/ritonavir based HAART among antiretroviral therapy naïve, HIV infected individuals presenting for care with CD4 cell counts. XVII International AIDS Conference; 13-18 August 2008; Mexico City. Mexico City: International AIDS Society; 2008.
4. Thwe M, Maung W, Par P, Myint B, Zaw M, Wilson N, et al. Epidemiological, clinical, biological characteristics and treatment outcomes of a cohort of HIV-TB patients enrolled in the integrated HIV care for tuberculosis patients programme (IHC) in Mandalay, Myanmar. XVII International AIDS Conference; 3-8 August 2008; Mexico City. Mexico City: International AIDS Society; 2008.
5. Kapogiannis B, Soe M, Nesheim S, Abrams E, Farley J, Palumbo P, et al. Trends in mortality in the pre and post HAART eras among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (PACTS) (1986-2004). XVII International AIDS Conference; 3-8 August 2008; Mexico City. Mexico City: International AIDS Society; 2008.
6. Rewari B, Bachani D, Garg R, Despande A, Rajasekharan S, Emmanuel KV, et al. Two-year treatment outcomes of the first-line antiretroviral therapy programme in India. XVII International AIDS Conference; 3-8 August 2008; Mexico City. Mexico City: International AIDS Society; 2008.
7. Harding R, Easterbrook P, Karus D, Raveis VH, Higginson IJ, Marconi K. Does palliative care improve outcomes for people with HIV/AIDS? A systematic review of the evidence. Sex Transm Infect 2005; 81:5-14.